Health Care News – Read More The Food and Drug Administration (FDA) on Thursday approved a higher dose of the Wegovy weight loss drug. The manufacturer, Novo Nordisk, increased the semaglutide injection by 4.8 mg to total 7.2 mg. The company says the higher dosage is recommended for those who taken the lower dose already for at least four weeks. Novo Nordisk…
FDA approves higher dose of Wegovy
HootMD curates medical news from trusted publishers. Follow the links in this article to read the full story at the original source.
